share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sendrow Jerrold

SEC announcement ·  Jan 31 16:28
Summary by Moomoo AI
Jerrold Sendrow, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], has engaged in a transaction involving the company's stock. The action took place on January 29, 2024. However, the details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting ownership stake, have not been disclosed in the announcement. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
Jerrold Sendrow, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], has engaged in a transaction involving the company's stock. The action took place on January 29, 2024. However, the details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting ownership stake, have not been disclosed in the announcement. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more